top of page
Search


Member Exclusives: Accessing Expertise on Value-Added Medicines
Welcome to our new website and a whole new world where expertise in value added medicines is just a click or request away. The 505(b)(2)...

VAMA Board
Jul 92 min read


Advancing 505(b)(2) Development: Top Strategies Revealed
Are you involved in the development and marketing of value-added medicines like 505(b)(2)s? If so, you may find the latest insights on...

VAMA Board
Jul 32 min read


Unlocking Commercial Value in 505b2s: Key Insights for Industry Leaders
Value-added medicines play a crucial role in the healthcare industry, offering innovative solutions to meet patients' needs. Recently,...

VAMA Board
Jun 211 min read


Pragmatic Drug Development
Implementing Congress’s Incentive to Use §505(b)(2)’s to Measure Clinical Benefit in Real World Settings 1. Background Congress enacted...

Edward J. Allera
Sep 5, 20249 min read


505b2s and Women’s Health Issues
505(b)(2)s and Women’s Health Issues By using the 505(b)(2) new drug application pathway, sponsors can add value to already approved...

Edward J. Allera
Jul 29, 20244 min read
bottom of page